rxstat › Drug prices › Acalabrutinib
Acalabrutinib (Calquence) price in Canada
No current shortage
Acalabrutinib 100 mg tablet costs about $145.77 per tablet on public drug plan price lists across 2 provinces, before the pharmacy's dispensing fee.
Acalabrutinib has no current shortage reported in Canada. No active reports are on file.
Price by province
| Strength and form | AB | NB | NS |
|---|---|---|---|
| 100 mg Tabletper tablet | $145.77not covered | $145.77 | $145.77 |
| 100 mg Capsuleper capsule | $142.77not covered | – | – |
| Plan coverage | Not covered | Special approval | Special approval |
What you'll pay at the pharmacy
These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.
Listed products by province
Alberta: 2 products
- Calquence 100 mg Capsule · AZC
- Calquence 100 mg Tablet · AZC
New Brunswick: 1 product
- Calquence 100 mg Tablet · AZE
Nova Scotia: 2 products
- Calquence 100 mg Tablet · AZE
- Calquence 100 mg Capsule · AZE
Shortage status
No shortage or discontinuation reports have been filed with Health Canada for Acalabrutinib. rxstat watches those reports through the day; sign up below to hear if that changes.
Common questions
How much does Acalabrutinib cost in Canada?
Acalabrutinib 100 mg tablet costs about $145.77 per tablet on public drug plan price lists across 2 provinces, before the pharmacy's dispensing fee.
Is Acalabrutinib covered by provincial drug plans?
On the public plans' own lists: Alberta: not covered; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.